Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
XaTek
AddedFeb 15, 2024
UpdatedJun 18, 2026
XaTek

XaTek

Series A

XaTek, an Ohio-based biomedical device company, innovates urgent healthcare needs with seasoned expertise since 2016.

HQ
Cleveland, OH, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

XaTek, founded in 2016 and based in Cleveland, Ohio, is a biomedical device company focused on addressing urgent healthcare needs. The company's core mission is to make clinical evaluation of whole-blood coagulation more accessible at the point of care. XaTek's flagship product, ClotChip®, utilizes dielectric spectroscopy to provide rapid and accurate assessments of blood coagulation, regardless of the underlying cause. This innovation aims to improve patient outcomes in critical care settings.

XaTek is led by a team of experienced inventors, entrepreneurs, and market innovators with a proven track record in the medical device industry. The company has garnered attention for its groundbreaking technology and has participated in various clinical trials to validate its efficacy. XaTek's impact is marked by its potential to revolutionize point-of-care diagnostics, making life-saving information readily available to healthcare providers when it matters most.

XaTek - Similar Companies

BioChip Labs logo

BioChip Labs

biochiplabs.com

Coagulo Medical Technologies logo

Coagulo Medical Technologies

coagulomed.com

Dawatek logo

Dawatek

Xheme logo

Xheme

xhemeinc.com

bTECH logo

bTECH

btechls.com

Xenter logo

Xenter

xentermd.com

XN Health logo

XN Health

xn-health.com

IR Medtek logo

IR Medtek

irmedtek.com

iFirst Medical Technologies logo

iFirst Medical Technologies

ifirstmedtech.com

HDO Health logo

HDO Health

Perosphere Technologies logo

Perosphere Technologies

perospheretech.com

Xoran Technologies logo

Xoran Technologies

xorantech.com

Xact Medical logo

Xact Medical

xactmedical.com

Abram Scientific logo

Abram Scientific

XableCath logo

XableCath

XaTek - Quick Facts

Who are XaTek's competitors?

Companies similar to XaTek include BioChip Labs, Coagulo Medical Technologies, Dawatek and Xheme.

When was XaTek founded?

XaTek was founded in 2016.

Where is XaTek's headquarters located?

XaTek's headquarters is located in Cleveland, OH, US.

When was XaTek's last funding round?

XaTek's most recent funding round was for $9.1M (USD) in July 2018.

How much has XaTek raised to-date?

As of Jul 11, 2018, XaTek has raised a total of $9.1M (USD).

How many employees does XaTek have?

XaTek has 6 employees as of Feb 4, 2024.

XaTek - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified